Ifng (human) recombinant protein 100 µg
Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
Points clés
Interferon-gamma (IFNG), or type II interferon, is a cytokine critical for innate and adaptive immunitésy against viral and intracellular bacterial infections and for tumor control. Aberrant IFNG expression is associated with a number of autoinflammatory and autoimmune diseases. The importance of IFNG in the immune system stems in part from its ability to inhibit viral replication directly, but most importantly derives from its immunostimulatory and immunomodulatory effects. IFNG is produced predominantly by natural killer (NK) and natural killer T (NKT) cells as part of the innate immune response, and by CD4 (MIM 186940) and CD8 (see MIM 186910) cytotoxic T lymphocyte (CTL) effector T cells once antigen-specific immunitésy develops (Schoenborn and Wilson, 2007 [PubMed 17981204]).[supplied by OMIM]
Garantie
Garantie 0 Mois
Description
Interferon-gamma (IFNG), or type II interferon, is a cytokine critical for innate and adaptive immunitésy against viral and intracellular bacterial infections and for tumor control. Aberrant IFNG expression is associated with a number of autoinflammatory and autoimmune diseases. The importance of IFNG in the immune system stems in part from its ability to inhibit viral replication directly, but most importantly derives from its immunostimulatory and immunomodulatory effects. IFNG is produced predominantly by natural killer (NK) and natural killer T (NKT) cells as part of the innate immune response, and by CD4 (MIM 186940) and CD8 (see MIM 186910) cytotoxic T lymphocyte (CTL) effector T cells once antigen-specific immunitésy develops (Schoenborn and Wilson, 2007 [PubMed 17981204]).[supplied by OMIM]
Caractéristiques
- Fournisseur
- FISHER SCIENTIFIC S.A.S.
- Marque
- ABNOVA
- Référence fabricant
- P3982
- Référence distributeur
- 16262000
- Vendu par
- 100 ug
- Quantité
- N/A
- Lieu de fabrication
- Taiwan
- Lieu de stockage
- France
- Délai de péremption à la date de livraison
- 12 mois
- Code à barre
- non
- Soumis à carboglace
- oui
- Libellé produit fabricant
- 100ug ifng (human) recombinant protein
- Certification
- RUO
- Marquage CE DIV
- non
- Type de produit
- protéine
- Type de protéine
- oui
- Type d'antibiotique
- non
- Type d'enzyme
- non
- Température de conservation (°C)
- -192 °C
- Température de transport
- carboglace
- Dispositif stérile
- non
- Type d'acide nucléique extrait
- non
- Origine humaine
- non
- Sans composant animal
- non
- Matière dangereuse
- non
- Autres caractéristiques
- Abnova Human IFNG (P01579, 144 amino acids) Partial Recombinant Protein, Format: Lyophilized, Formulation: Lyophilized, Host Species: Escherichia coli, Molecular Weight: 16.9kDa, Protein Tag: none, Quantity: 100 ug, Recombinant: Yes, Regulatory Statu
- Classification REACH
- non
- Code douanier
- 38229000
- Nomenclature Nacres
- NA.55
- Nomenclature CEA
- SGP01
- Nomenclature IRSN
- 273
- Nomenclature INSERM
- NA.NA55
- Nomenclature CNRS
- NA55
- Nomenclature CHU
- 18.551
- Nomenclature DGOS
- LD10AOOO
- Type d'échantillon
- protéine
- Type d’application
- ELISA, Western-Blot
- Reprise en cas d’erreur client
- non
- Domaine de recherche
- protéomique